@article{997bc769c7584f8d842de3fba751e378,
title = "An Open-Label, Phase Ib Study of Duvelisib (IPI-145) in Combination with Bendamustine, Rituximab or Bendamustine/Rituximab in Select Subjects with Lymphoma or Chronic Lymphocytic Leukemia",
author = "Ian Flinn and Patel, \{Manish R.\} and Maris, \{Michael B\} and Jeffrey Matous and Mohamad Cherry and Berdeja, \{Jesus G.\}",
note = "623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster III | Ian Flinn, Manish R. Patel, Michael B Maris, Jeffrey Matous, Mohamad Cherry, Jesus G. Berdeja; An Open-Label, Phase Ib Study of Duvelisib (IPI-145) in Combination with Bendamustine, Rituximab or Bendamustine/Rituximab in Select Subjects with Lymphoma or Chronic Lymphocytic Leukemia. 2014; 124 (21): 4422.",
year = "2014",
month = dec,
day = "6",
doi = "10.1182/BLOOD.V124.21.4422.4422",
language = "American English",
volume = "124",
journal = "Blood",
publisher = "American Society of Hematology",
number = "21",
}